SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Everhart JE, ed. Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC: US Government Printing Office; 1994. NIH publication 94-1447.
  • 2
    Guimaro MS, Lacerda SS, Karam CH, Ferraz-Neto BH, Andreoli PB. Psychosocial profile of patients on the liver transplant list. Transplant Proc 2008; 40: 782-784.
  • 3
    Ewusi-Mensah I, Saunders JB, Wodak AD, Murray RM, Williams R. Psychiatric morbidity in patients with alcoholic liver disease. Br Med J (Clin Res Ed) 1983; 287: 1417-1419.
  • 4
    Kelly M, Chick J, Gribble R, Gleeson M, Holton M, Winstanley J, et al. Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol Alcohol 2006; 41: 278-283.
  • 5
    Dobbels F, Vanhaecke J, Dupont L, Nevens F, Verleden G, Pirenne J, De Geest S. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009; 87: 1497-1504.
  • 6
    Maricle RA, Hosenpud JD, Norman DJ, Woodbury A, Pantley GA, Cobanoglu AM, Starr A. Depression in patients being evaluated for heart transplantation. Gen Hosp Psychiatry 1989; 11: 418-424.
  • 7
    Owen JE, Bonds CL, Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics 2006; 47: 213-222.
  • 8
    Skotzko CE, Rudis R, Kobashigawa JA, Laks H. Psychiatric disorders and outcome following cardiac transplantation. J Heart Lung Transplant 1999; 18: 952-956.
  • 9
    Loberiza FR Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118-2126.
  • 10
    Dobbels F, Skeans MA, Snyder JJ, Tuomari AV, Maclean JR, Kasiske BL. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis 2008; 51: 819-828.
  • 11
    Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549-562.
  • 12
    Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
  • 13
    R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
  • 14
    DiMartini A, Dew MA, Javed L, Fitzgerald MG, Jain A, Day N. Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psychosomatics 2004; 45: 517-523.
  • 15
    Surman OS, Cosimi AB, DiMartini A. Psychiatric care of patients undergoing organ transplantation. Transplantation 2009; 87: 1753-1761.
  • 16
    De Geest S, Dobbels F, Martin S, Willems K, Vanhaecke J. Clinical risk associated with appointment noncompliance in heart transplant recipients. Prog Transplant 2000; 10: 162-168.
  • 17
    Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769-776.
  • 18
    Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry; doi:10.1016/j.pnpbp.2010.04.011.
  • 19
    Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009; 169: 2128-2139.
  • 20
    Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 2009; 339: b2880. doi: 10.1136/bmj.b2880.